{"cluster": 37, "subcluster": 0, "abstract_summ": "BACKGROUND: Understanding the epidemiology and clinical course of multisystem inflammatory syndrome in children (MIS-C) and its temporal association with coronavirus disease 2019 (Covid-19) is important, given the clinical and public health implications of the syndrome.Many of these cases feature a toxic shock-like syndrome or Kawasaki-like syndrome in the setting of SARS-CoV-2 positive diagnostic testing and the CDC has termed this presentation Multisystem Inflammatory Syndrome (MIS-C).We report a series of febrile pediatric patients with acute heart failure potentially associated with SARS-CoV-2 infection and the multisystem inflammatory syndrome in children (MIS-C) as defined by the US Centers for Disease Control.The comparison with patients with KD and KD shock syndrome provides insights into this syndrome, and suggests this disorder differs from other pediatric inflammatory entities.The New York State Department of Health (NYSDOH) established active, statewide surveillance to describe hospitalized patients with the syndrome.", "title_summ": "A Case ReportPaediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohortIntensive care admissions of children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in the UK: a multicentre observational studyAcute myocarditis and multisystem inflammatory emerging disease following SARS-CoV-2 infection in critically ill childrenMultisystem Inflammatory Syndrome in Children in New York StateToxic shock-like syndrome and COVID-19: A case report of multisystem inflammatory syndrome in children (MIS-C)Assessment of Acute Acral Lesions in a Case Series of Children and Adolescents During the COVID-19 PandemicNeuropsychiatric Symptoms in an Adolescent Boy with Multisystem Inflammatory Syndrome in Children (MIS-C)Multisystem Inflammatory Syndrome in U.S. Children and AdolescentsPaediatric Inflammatory Multisystem Syndrome: Temporally Associated with SARS-CoV-2 (PIMS-TS): Cardiac Features, Management and Short-Term Outcomes at a UK Tertiary Paediatric HospitalSerology in Children with Multisystem Inflammatory Syndrome (MIS-C) associated with COVID-19A Saudi G6PD Deficient Girl Died with Pediatric Multisystem Inflammatory Syndrome-COVID-19A Case of Pediatric Multisystem Inflammatory Syndrome Temporally Associated with COVID-19 in South Dakota.Features of COVID-19 post-infectious cytokine release syndrome in children presenting to the emergency departmentMultisystem Inflammatory Syndrome in Children (MIS-C) Associated with SARS-CoV-2 Infection: A Multi-institutional Study from New York CitySevere Cardiac Dysfunction in a Patient with Multisystem Inflammatory Syndrome in Children Associated with COVID-19: Retrospective Diagnosis of a Puzzling Presentation.Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2.Multisystem Inflammatory Syndrome in Children (MIS-C) Related to COVID-19: A New York City Experience.Is it Kawasaki shock syndrome, Kawasaki-like disease or pediatric inflammatory multisystem disease?", "title_abstract_phrases": "Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2.Importance In communities with high rates of coronavirus disease 2019, reports have emerged of children with an unusual syndrome of fever and inflammation.Multisystem Inflammatory Syndrome in U.S. Children and AdolescentsBACKGROUND: Understanding the epidemiology and clinical course of multisystem inflammatory syndrome in children (MIS-C) and its temporal association with coronavirus disease 2019 (Covid-19) is important, given the clinical and public health implications of the syndrome.CONCLUSIONS: The emergence of multisystem inflammatory syndrome in children in New York State coincided with widespread SARS-CoV-2 transmission; this hyperinflammatory syndrome with dermatologic, mucocutaneous, and gastrointestinal manifestations was associated with cardiac dysfunction.Many of these cases feature a toxic shock-like syndrome or Kawasaki-like syndrome in the setting of SARS-CoV-2 positive diagnostic testing and the CDC has termed this presentation Multisystem Inflammatory Syndrome (MIS-C).The comparison with patients with KD and KD shock syndrome provides insights into this syndrome, and suggests this disorder differs from other pediatric inflammatory entities."}